Ko Un Park1,2, Kristin Kyrish1, John Terrell3, Min Yi1, Abigail S Caudle1, Kelly K Hunt1, Henry M Kuerer1, Isabelle Bedrosian1, Alastair Thompson1,4, Sarah M DeSnyder1. 1. Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2. Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio. 3. Department of Quality Measurement and Engineering, The University of Texas MD Anderson Cancer Center, Houston, Texas. 4. Department of Surgery, Baylor College of Medicine, Houston, Texas.
Abstract
BACKGROUND: Few guidelines exist for an opioid prescription after breast surgical oncology (BSO) procedures. We sought to characterize opioid prescribing and use patterns by surgery type. METHODS: Patients (n = 332) undergoing BSO procedure were surveyed one week postoperatively for opioid use. The surgeons were surveyed about pain management preferences surgery type. CPT codes were collected for 2017 to calculate the amount of opioids used by surgery type relative to surgeon preference. RESULTS: Mean oral morphine equivalent (OME) preferred prescription for surgeons who did not tailor prescriptions by surgery type (n = 7, group A) was 177, whereas for those who did tailor (n = 10, group B) varied from 137 to 257 OME. There was a significant difference in opioid use by surgery type: 32 OME for segmental mastectomy (SM) ± sentinel lymph node dissection (SLND), 63 for SM + axillary lymph node dissection (ALND), 76 for total mastectomy (TM) ± SLND, 115 for TM + ALND (P < 0.001). Considering the type of surgeries performed group A prescribers would have 229190 unused OME and group B would have 230826 in 1 year. CONCLUSION: Wide variation in opioid use by BSO procedure type was noted with substantial unused OME regardless ofprescribing preference. Evidence-based guidelines are needed to tailor analgesic prescriptions according to the need.
BACKGROUND: Few guidelines exist for an opioid prescription after breast surgical oncology (BSO) procedures. We sought to characterize opioid prescribing and use patterns by surgery type. METHODS:Patients (n = 332) undergoing BSO procedure were surveyed one week postoperatively for opioid use. The surgeons were surveyed about pain management preferences surgery type. CPT codes were collected for 2017 to calculate the amount of opioids used by surgery type relative to surgeon preference. RESULTS: Mean oral morphine equivalent (OME) preferred prescription for surgeons who did not tailor prescriptions by surgery type (n = 7, group A) was 177, whereas for those who did tailor (n = 10, group B) varied from 137 to 257 OME. There was a significant difference in opioid use by surgery type: 32 OME for segmental mastectomy (SM) ± sentinel lymph node dissection (SLND), 63 for SM + axillary lymph node dissection (ALND), 76 for total mastectomy (TM) ± SLND, 115 for TM + ALND (P < 0.001). Considering the type of surgeries performed group A prescribers would have 229190 unused OME and group B would have 230826 in 1 year. CONCLUSION: Wide variation in opioid use by BSO procedure type was noted with substantial unused OME regardless ofprescribing preference. Evidence-based guidelines are needed to tailor analgesic prescriptions according to the need.
Authors: Uzma Shamim Seth; Sughra Perveen; Tanweer Ahmed; Mohammad Taha Kamal; Jehangir Ali Soomro; Munira Murtaza Khomusi; Maha Kamal Journal: Cureus Date: 2022-04-13
Authors: Samantha Eiffert; Andrea L Nicol; Edward F Ellerbeck; Joanna Veazey Brooks; Andrew W Roberts Journal: Support Care Cancer Date: 2020-03-25 Impact factor: 3.603
Authors: Nicholas W Eyrich; Kenneth R Sloss; Ryan A Howard; Michael P Klueh; Michael J Englesbe; Jennifer F Waljee; Chad M Brummett; Michael S Sabel; Lesly A Dossett; Jay S Lee Journal: J Surg Oncol Date: 2020-10-30 Impact factor: 3.454